The circulating levels of LL–37 in SSc patients were investigated as lower LL-37 levels may be associated with the development of ILD. PubMed, Clin Rheumatol, 01/20/2015. (Also see: Pulmonary Fibrosis Biomarkers and Scleroderma Biomarkers)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.